Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 6/20 | 0.56 |
| ▸ | DRD2 | P14416 | 1/20 | 0.56 |
| ▸ | KDM1A | O60341 | 1/20 | 0.52 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4047901 | 0.98 | SLC6A4 (0.54) | SLC6A4DRD2KDM1AMTNR1ASLC6A2 | |
| SCHEMBL168782 | 0.98 | SLC6A4 (0.54) | SLC6A4DRD2KDM1AMTNR1ASLC6A2 | |
| SCHEMBL30032791 | 0.98 | SLC6A4 (0.54) | SLC6A4DRD2KDM1AMTNR1ASLC6A2 | |
| SCHEMBL3968194 | 0.96 | SLC6A4 (0.56) | SLC6A4DRD2KDM1AMTNR1ASLC6A2 | |
| SCHEMBL30477104 | 0.91 | SLC6A4 (0.59) | SLC6A4DRD2KDM1AMTNR1ASLC6A2 | |
| SCHEMBL248440 | 0.91 | SLC6A4 (0.59) | SLC6A4DRD2KDM1AMTNR1ASLC6A2 | |
| SCHEMBL23301397 | 0.87 | HPRT1 (0.50) | SLC6A4DRD2KDM1AMTNR1ACYP1B1 | |
| SCHEMBL7746921 | 0.87 | HPRT1 (0.50) | SLC6A4DRD2KDM1AMTNR1AHRH3 | |
| SCHEMBL6567045 | 0.84 | HPRT1 (0.52) | SLC6A4DRD2KDM1AMTNR1ACYP1B1 | |
| SCHEMBL7648248 | 0.83 | SLC6A4 (0.53) | SLC6A4DRD2KDM1AMTNR1ASLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115594652-A | Amine compound and organic light-emitting device thereof | 长春海谱润斯科技股份有限公司（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-115417806-A | Carbazole compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2022-12-02 | — | — | CN | claimed |
| CN-111302880-B | Application of iron catalyst in reduction coupling reaction and preparation method of aromatic ring and heterocyclic derivative | 川北医学院 | 2022-09-13 | — | — | CN | claimed |
| CN-114907217-A | Triamine compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2022-08-16 | — | — | CN | claimed |
| CN-114773286-A | Nitrogen-containing heterocyclic organic compound and organic light-emitting device thereof | 长春海谱润斯科技股份有限公司 | 2022-07-22 | — | — | CN | claimed |
| CN-114656434-A | Tetramine compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2022-06-24 | — | — | CN | claimed |
| CN-114621181-A | Star-shaped tetramine derivative and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2022-06-14 | — | — | CN | claimed |
| CN-114573536-A | Star triarylamine derivative and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2022-06-03 | — | — | CN | claimed |
| EP-1654225-A4 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONISTS | AMGEN INC (US) | 2007-11-28 | — | — | EP | claimed |
| EP-1654225-A2 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONISTS | Amgen, Inc. (US) | 2006-05-10 | — | — | EP | claimed |
| US-20050256161-A1 | Melanin concentrating hormone receptor antagonists | AMGEN INC. | 2005-11-17 | — | — | US | claimed |
| WO-2005019240-A2 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONISTS | AMGEN, INC. (US) | 2005-03-03 | — | — | WO | claimed |
| EP-0061137-B1 | USE OF NAPHTHA IN CARBO-METALLIC OIL CONVERSION | ASHLAND OIL, INC. (US) | 1987-09-30 | — | — | EP | claimed |
| CN-116589496-B | Star-shaped triamine compound and organic light-emitting device thereof | 长春海谱润斯科技股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-117384118-B | Triarylamine compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-122069935-A | Organic electroluminescent device | 长春海谱润斯科技股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| WO-2005019240-A2 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONISTS | AMGEN, INC. (US) | 2005-03-03 | — | — | WO | disclosed |
| US-20040067436-A1 | Polymerizable silicon-containing compound, manufacturing method, polymer, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-04-08 | — | — | US | disclosed |
| US-6649768-B1 | Converting, in dimethyl sulfoxide, 3-haloacetylpyridine to glyoxal compound, reacting with ammonia and aldehyde to produce 3-(4-imidazolyl)pyridine compound | SUMIKA FINE CHEMICALS CO., LTD. (JP) | 2003-11-18 | — | — | US | disclosed |
| US-3936473-A | COPPER OR NOBLE METAL SALT, OXYGEN AND ORGANIC ACID CATALYST | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256161-A1 | Melanin concentrating hormone receptor antagonists | MCHR1, MC1R, NPY1R | SLC6A4 158/4885DRD2 182/4885KDM1A 2300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.